IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Oral Dispersible Film Containing Eletriptan Hydrobromide for Treatment of Migraine: Design, Formulation, Evaluation and Optimization

Author: SWAPNIL PALVE, RAJENDRA MOGAL, NAYAN GUJARATHI, ANIL JADHAV
Abstract: The objective of present work was to develop rapidly orally dispersing film of eletriptan hydrobromide for treatment of migraine headache. The excipients used for preparation of rapidly orally dispersing film were screened for compatibility with the help of Differential Scanning Calorimetry (DSC) and Oral Dispersible Film (ODF) was fabricated by solvent casting method using compatible excipients. DSC thermograms do not shown significant change in endothermic behavior, which indicated all excipients were compatible with the drug.ODF prepared with Hydroxylpropyl Methylcellulose (HPMC) E-15 was transparent, non-tacky, flexible, disintegrate within specified time, with good tensile strength. The fabricated film was evaluated for disintegration time, dissolution profile, folding endurance, tensile strength, surface pH, thickness etc. 32 full factorial design was used for optimization of ODF by selecting concentration of PG (X1) and concentration of HPMC E-15 (X2) as an independent variables and disintegration time (Y1) as a dependent variable. The optimized ODF disintegrate within 25.65 sec and around 90% drug content. Prepared ODF rapidly disintegrate which indicate fast therapeutic effect which required in acute attack of migraine.
Keyword: Eletriptan hydrobromide, Oral Dispersible Film, Migraine, Optimization, Tensile Strength
DOI: https://doi.org/10.31838/ijpr/2019.11.04.054
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus